- Sintilimab Plus P-Gemox (Pegaspargase, Gemcitabine and Oxaliplatin) Regimen for Newly-Diagnosed Advanced, Extranodal Natural Killer/T Cell Lymphoma, Nasal Type: A Multicenter, Phase 2 Cohort of the Open-Label Spirit StudyCai, Qingqing; Liu, Panpan; Xia, Yi; Cai, Jun; Huang, Huiqiang; Li, Zhiming; Zhou, Hui; Li, Yajun; Wang, Hanyu; Huang, Ying; Yan, Gao; Pan, Xueyi64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), New Orleans, LA, 2022-12-10 To 2022-12-13.被引 3
- PD-1 Antibody (Sintilimab) Plus Histone Deacetylase Inhibitor (Chidamide) for the Treatment of Refractory or Relapsed Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (r/r ENKTL): Updates of the Phase Ib/II Scent StudyYan, Gao; Zhang, Liling; Li, Wenyu; Wei, Xu; Feng, Ru; Li, Xue-Ping; Chen, Yu; Wu, Huijing; Wang, Xiaoxiao; Bai, Bing; Huang, Huiqiang65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
- Mitoxantrone hydrochloride liposome injection in the treatment of recurrent/metastatic head and neck cancers: A multicenter, open-label, single-arm, phase Ib study.Yang, Hang; Wang, Xicheng; Zhang, Hong; Peng, Jiyong; Li, Weidong; Liu, Yanyan; Hu, Jianbing; Zhou, Hui; Zhang, Bing; Liu, Jixiang; Lin, Shunhuan; Luo, Hao; Hu, Jie; Li, ZhimingAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 2022-06-03 To 2022-06-07.
会议论文
Combination of mitoxantrone hydrochloride liposome with pegaspargase in patients with extranodal NK/T-cell lymphoma: A phase I/II clinical trial
4阅读
